関連する実験動画
Updated: Sep 9, 2025

04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.2K
肺機能障害と脊椎関節炎のリスクとの関連:英国バイオバンクの横断研究
Ying Zhu1,2, Zijian Kang3, Chen Zhu4
1Senior Department of Pulmonary and Critical Care Medicine, The Eighth Medical Center of Chinese PLA General Hospital, Beijing, China.
Therapeutic advances in musculoskeletal disease
|September 4, 2025
まとめ
保存比障害スピロメトリー (PRISm) の個人は,より高い脊椎関節炎 (SpA) の流行と発生率を示しています. 肺機能障害は SpA リスクの増加と関連しており,重要な関連性を示しています.
科学分野:
- 肺医学
- リウマトロジ
- 流行病学について
背景:
- 肺機能障害は,脊椎関節炎 (SpA) の患者で観察されています.
- 肺機能と SpA を関連付ける既存の証拠は,包括的な要約を必要とします.
研究 の 目的:
- 肺機能障害と SpA の流行および発生率との関連を調査する.
- 英国のバイオバンクのデータを活用して 疫学的な分析を行う.
主な方法:
- UK Biobankのデータを用いた横断的および前向きなコホート研究設計
- スピロメトリーとHLA-B27データを持つ41万1780人の参加者を含めた.
- ロジスティック回帰,コックス回帰,および制限立方脊髄 (RCS) 分析が行われました.
主要な成果:
- 保存比低下スピロメトリー (PRISm) (OR: 1.538) を有する個体において,SPAの有意に高い罹患率を示した.
- PRISmは,14. 64年の間,発症リスクの上昇と関連していた (aHR: 1. 249).
- FEV1 %pred と SpA 発生率 (p < 0. 001) の間には非線形的な関係が見られた.
結論:
- 肺機能障害と SpA の流行の間には重要な関連性があります.
- PRISmを患っている人は,インシデントSpaAを発症するリスクが高くなります.
さらに関連する動画
関連する概念動画
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
COPD: Pathogenesis and Clinical Features
512
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
512
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K

